M. Friede

Efficacy and Safety of Isopropanolic Black Cohosh Extract for Climacteric Symptoms

Ruediger G. W. Osmers, M. Friede, Eckehard Liske et al. · Obstetrics and Gynecology · 2005 · 210 citations

Efficacy and Safety of 6.25 mg t.i.d. Feverfew CO₂-Extract (MIG-99) in Migraine Prevention — A Randomized, Double-Blind, Multicentre, Placebo-Controlled Study

H-C Diener, V. Pfaffenrath, J Schnitker et al. · Cephalalgia · 2005 · 159 citations

No Relevant Interaction with Alprazolam, Caffeine, Tolbutamide, and Digoxin by Treatment with a Low-Hyperforin St John’s Wort Extract

Gerhard Arold, Frank Donath, A. Maurer et al. · Planta Medica · 2005 · 98 citations

Black cohosh with or without St. John's wort for symptom-specific climacteric treatment—Results of a large-scale, controlled, observational study

Volker Briese, U Stammwitz, M. Friede et al. · Maturitas · 2007 · 59 citations

Clinical Epidemiology, Black Cohosh, Observational Study +3

Indirect meta-analysis of randomised placebo-controlled clinical trials on rasagiline and selegiline in the symptomatic treatment of Parkinson’s disease

Wolfgang H. Jost, M. Friede, Jörg Schnitker · Basal Ganglia · 2012 · 21 citations

Meta-analysis, Parkinson Disease, Symptomatic Treatment +8